BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31062898)

  • 21. Cancer risk following post-transplant lymphoproliferative disorders in solid organ transplant recipients.
    Mahale P; Engels EA; Lynch CF; Morton LM
    Br J Haematol; 2019 Jul; 186(2):347-351. PubMed ID: 30820931
    [No Abstract]   [Full Text] [Related]  

  • 22. Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient.
    Dharnidharka VR; Douglas VK; Hunger SP; Fennell RS
    Pediatr Transplant; 2004 Feb; 8(1):87-90. PubMed ID: 15009846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posttransplant lymphoproliferative disorder in pediatric patients: Survival rates according to primary sites of occurrence and a proposed clinical categorization.
    L'Huillier AG; Dipchand AI; Ng VL; Hebert D; Avitzur Y; Solomon M; Ngan BY; Stephens D; Punnett AS; Barton M; Allen UD
    Am J Transplant; 2019 Oct; 19(10):2764-2774. PubMed ID: 30884098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypogammaglobulinemia and bacterial infections following pediatric post-transplant lymphoproliferative disorder in the rituximab era.
    Chiou FK; Beath SV; Patel M; Gupte GL
    Pediatr Transplant; 2019 Sep; 23(6):e13519. PubMed ID: 31209964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose chemotherapy for children with post-transplant lymphoproliferative disease.
    Gross TG
    Recent Results Cancer Res; 2002; 159():96-103. PubMed ID: 11785850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posttransplant lymphoproliferative disorder: a pictorial review.
    Burney K; Bradley M; Buckley A; Lyburn I; Rye A; Hopkins R
    Australas Radiol; 2006 Oct; 50(5):412-8. PubMed ID: 16981935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose Chemotherapy with Stem Cell Rescue Provided Durable Remission for Classical Hodgkin Lymphoma-type Post-transplant Lymphoproliferative Disorder after Unrelated Cord Blood Transplantation: A Case Report and Review of the Literature.
    Itonaga H; Kato T; Fujioka M; Taguchi M; Taniguchi H; Imaizumi Y; Yoshida S; Miyoshi H; Moriuchi Y; Ohshima K; Miyazaki Y
    Intern Med; 2017; 56(14):1873-1877. PubMed ID: 28717085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment and outcomes of post-transplant lymphoproliferative disease: a single institution study.
    Buadi FK; Heyman MR; Gocke CD; Rapoport AP; Hakimian R; Bartlett ST; Sarkodee-Adoo C
    Am J Hematol; 2007 Mar; 82(3):208-14. PubMed ID: 17022049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the posttransplant lymphoproliferative disorder subtype on survival.
    Koff JL; Li JX; Zhang X; Switchenko JM; Flowers CR; Waller EK
    Cancer; 2018 Jun; 124(11):2327-2336. PubMed ID: 29579330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics of post-transplant lymphoproliferative disorders.
    Morrison VA; Dunn DL; Manivel JC; Gajl-Peczalska KJ; Peterson BA
    Am J Med; 1994 Jul; 97(1):14-24. PubMed ID: 8030652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autopsy pathology of pediatric posttransplant lymphoproliferative disorder.
    Collins MH; Montone KT; Leahey AM; Hodinka RL; Salhany KE; Belchis DA; Tomaszewski JE
    Pediatrics; 2001 Jun; 107(6):E89. PubMed ID: 11389287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients.
    Green M; Michaels MG; Webber SA; Rowe D; Reyes J
    Pediatr Transplant; 1999 Nov; 3(4):271-81. PubMed ID: 10562971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small intestinal involvement by lymphoproliferative disorders post-renal transplantation: a report from the post-transplant lymphoproliferative disorder international survey.
    Khedmat H; Taheri S
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):487-94. PubMed ID: 23640619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment.
    Chan TS; Hwang YY; Gill H; Au WY; Leung AY; Tse E; Chim CS; Loong F; Kwong YL
    Clin Transplant; 2012; 26(5):679-83. PubMed ID: 22324300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update.
    Dierickx D; Tousseyn T; De Wolf-Peeters C; Pirenne J; Verhoef G
    Leuk Lymphoma; 2011 Jun; 52(6):950-61. PubMed ID: 21338285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
    Pinho-Apezzato ML; Tannuri U; Tannuri AC; Mello ES; Lima F; Gibelli NE; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Andrade WC; Miyatani HT
    Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
    Gross TG; Bucuvalas JC; Park JR; Greiner TC; Hinrich SH; Kaufman SS; Langnas AN; McDonald RA; Ryckman FC; Shaw BW; Sudan DL; Lynch JC
    J Clin Oncol; 2005 Sep; 23(27):6481-8. PubMed ID: 16170157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single-center experience of post-transplant lymphoproliferative disorder (PTLD) cases after pediatric liver transplantation: Incidence, outcomes, and association with food allergy.
    Barış Z; Özçay F; Yılmaz Özbek Ö; Haberal N; Sarıalioğlu F; Haberal M
    Turk J Gastroenterol; 2018 May; 29(3):354-360. PubMed ID: 29755021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk-adapted Treatment for Severe B-Lineage Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation in Children.
    Giraldi E; Provenzi M; Conter V; Colledan M; Bolognini S; Foglia C; Sebastiani R; Fiocchi R; Gianatti A; DʼAntiga L; Rambaldi A
    Transplantation; 2016 Feb; 100(2):437-45. PubMed ID: 26270449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum-free light chains adjusted for renal function are a potential biomarker for post-transplant lymphoproliferative disorders.
    Borrows R; Scheer A; Cockwell P; Braun F; Anagnostopoulos I; Riess H; Zimmermann H; Trappe RU
    Ann Hematol; 2019 Mar; 98(3):625-632. PubMed ID: 30680506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.